Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

67.67
-0.6300-0.92%
Volume:763.31K
Turnover:51.92M
Market Cap:13.25B
PE:-18.96
High:69.99
Open:69.26
Low:67.43
Close:68.30
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.47
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.27
PE(LYR):-17.88

Loading ...

Jan 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 26, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 26, 2021

Major Issues Report

8-K - Current report
Jan 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 12, 2021

Major Issues Report

8-K - Current report
Jan 12, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 04, 2021

Major Issues Report

8-K - Current report
Dec 11, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 06, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Major Issues Report

8-K - Current report
Oct 15, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Business Combinations

425 - Prospectuses and communications, business combinations